Gentex Corporation Acquires BioConnect

Gentex Corporation Acquires VOXX International Corporation

April 1, 2025

Automotive

Gentex Corporation completed the acquisition of VOXX International Corporation in an all-cash transaction at $7.50 per share, closing April 1, 2025 after VOXX stockholders approved the merger. Gentex says the purchase expands its automotive and consumer electronics capabilities — including VOXX’s distribution network, EyeLock biometric technology and premium audio brands — to accelerate growth in smart home, automotive OEM/aftermarket and consumer products.

Gentex Corporation Acquires eSight

January 7, 2024

Medical Devices

Gentex Corporation announced an asset acquisition of eSight to develop and manufacture next-generation mobile electronic eyewear for people with visual impairments. Gentex said it will leverage its digital vision, software and manufacturing expertise to advance eSight technology and feature the next-gen devices at CES 2024.

BioConnect Acquires Silent Partner Technologies

January 10, 2024

Cloud & SaaS

BioConnect, a Toronto-based biometric and identity trust platform provider, has acquired Silent Partner Technologies (SPT), a Tampa-based RFID asset and inventory management software company. The acquisition expands BioConnect's Trust Platform capabilities to offer cloud-based smart safes, lockers, cabinets and vehicle solutions that provide end-to-end chain-of-custody and asset tracking for markets such as EMS/Fire, fleet management and heavy machinery compliance.

Zetron Acquires GeoConex Corporation

February 16, 2023

Telecommunications

Zetron has acquired GeoConex Corporation, a developer and integrator of public safety and homeland security communications systems, making GeoConex a wholly owned division. The acquisition, disclosed by Zetron's parent Codan Limited on the ASX, expands Zetron's computer-aided dispatch, integration, development and support capabilities across mission-critical communications and homeland security markets.

Intus Bio Acquires Pattern Genomics

June 28, 2023

Biotechnology

Intus Biosciences (Intus Bio) has acquired Pattern Genomics, integrating Pattern's advanced genomic analysis and machine learning tools into Intus Bio's Titan-1 microbiome assay and analysis platform. The acquisition, supported by investor Connecticut Innovations, brings Pattern Genomics' founder Daniel Fasulo into Intus Bio as Head of IT and Bioinformatics to accelerate capability expansion and biomarker discovery across healthcare and pharmaceutical end markets.

Discovery Life Sciences Acquires Gentest Business from Corning Incorporated

April 5, 2022

Biotechnology

Discovery Life Sciences has acquired the Gentest business unit from Corning Incorporated to expand its in vitro ADME and toxicology reagent and services offering. The deal complements Discovery’s recent acquisition of In Vitro ADMET Laboratories (IVAL) and strengthens its hepatocyte, microsome and ADME-related product and contracted research capabilities for pharmaceutical and life sciences customers.